Not Yet RecruitingNot Applicable

S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem

100 participantsStarted 2022-04

Plain-language summary

Post-market, prospective, non randomized, open label, multicentre, clinical study analysing outcomes of shoulder arthroplasty with SMR TT Hybrid Glenoid with or without SMR Cementless Finned Short Stem

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Primary osteoarthritis;
✓. Secondary osteoarthritis;
✓. Post-traumatic arthritis;
✓. Rheumatoid arthritis;
✓. Avascular necrosis
✓. acute fractures of the humeral head that cannot be treated with other fracture fixation methods;
✓. cuff tear arthropathy (only in combination with CTA Heads);
✓. Glenoid arthrosis without excessive glenoid bone loss: A1, A2 and B1 according to Walch classification.

What they're measuring

Proportion of patients reaching a clinical progression from baseline to 24-month follow-up

Timeframe: 24 Months

Trial details

NCT IDNCT05314387

SponsorLimacorporate S.p.a

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-04

Contact for this trial

Laura Sanchez

817-233-1686 laura.sanchez@limacorporate.com

View on ClinicalTrials.gov More Shoulder Arthritis trials